MIM
ZBH icon

Moseley Investment Management’s Zimmer Biomet ZBH Stock Holding History

Moseley Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,952
Closed -$337K – 130
2019
Q2 		$337K Hold
2,952
– – 0.31% 91
2019
Q1 		$366K Buy
+2,952
New +$335K 0.38% 74

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Moseley Investment Management's ZBH Position: Q3 2019 in Review

Moseley Investment Management sold out of Zimmer Biomet (ZBH) in Q3 2019, closing a stake of 2,952 shares — an estimated $337K sold.

Moseley Investment Management first reported a position in ZBH in Q1 2019 and held it in 2 quarters. The position peaked at $366K in Q1 2019. 896 funds tracked by Wall St. Rank hold ZBH as of Q3 2019.

  • Moseley Investment Management reported no remaining Zimmer Biomet position as of Q3 2019 after selling out during the quarter.
  • Moseley Investment Management sold 2,952 Zimmer Biomet shares in Q3 2019, an estimated $337K.
  • Moseley Investment Management first reported a position in Zimmer Biomet in Q1 2019 and held it in 2 quarters.
  • Moseley Investment Management's Zimmer Biomet position peaked at $366K in Q1 2019.
  • 896 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2019.

Based on Moseley Investment Management's 13F filing for Q3 2019, filed 30 Oct 2019.